AZD2115 Single Ascending Dose Study

NCT01283984 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease
Lung Disease Causing Persistent Narrowing of the Airways

Interventions

DRUG: AZD2115
DRUG: Placebo

Sponsor

AstraZeneca